M&T Bank’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

M&T Bank’s Portfolio SPPI Stock Details SPPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-15,819	Closed	-$136K	–	1668
2019 Q2	$136K	Sell	15,819 -12,438	-44%	-$111K	﹤0.01%	1472
2019 Q1	$302K	Sell	28,257 -12,646	-31%	-$135K	﹤0.01%	1194
2018 Q4	$358K	Buy	40,903 +11,753	+40%	+$150K	﹤0.01%	1043
2018 Q3	$489K	Sell	29,150 -12,547	-30%	-$272K	﹤0.01%	1012
2018 Q2	$874K	Sell	41,697 -4,918	-11%	-$91.1K	﹤0.01%	806
2018 Q1	$750K	Sell	46,615 -10	-0%	-$198	﹤0.01%	858
2017 Q4	$883K	Buy	46,625 +1,367	+3%	+$24.8K	﹤0.01%	810
2017 Q3	$637K	Buy	45,258 +15,109	+50%	+$137K	﹤0.01%	904
2017 Q2	$225K	Buy	+30,149	New	+$197K	﹤0.01%	1357
2014 Q4	–	Sell	-14,636	Closed	-$119K	–	2273
2014 Q3	$119K	Buy	+14,636	New	+$115K	﹤0.01%	1998

Other funds holding SPPI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

M&T Bank's SPPI Position: Q3 2019 in Review

M&T Bank sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2019, closing a stake of 15,819 shares — an estimated $136K sold.

M&T Bank first reported a position in SPPI in Q3 2014 and held it in 10 quarters. The position peaked at $883K in Q4 2017. 167 funds tracked by Wall St. Rank hold SPPI as of Q3 2019.

M&T Bank reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2019 after selling out during the quarter.
M&T Bank sold 15,819 Spectrum Pharmaceuticals Inc shares in Q3 2019, an estimated $136K.
M&T Bank first reported a position in Spectrum Pharmaceuticals Inc in Q3 2014 and held it in 10 quarters.
M&T Bank's Spectrum Pharmaceuticals Inc position peaked at $883K in Q4 2017.
167 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2019.

Based on M&T Bank's 13F filing for Q3 2019, filed 12 Nov 2019.